跳至主要内容
临床试验/NCT03159507
NCT03159507已完成4 期

Effect of Omega-3 Index on Cellular Metabolism and Quality of Life Following the Administration of a Customized Dose of Omega-3 Oil

SCF Pharma2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2017年10月2日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
16
试验地点
2
主要终点
Omega-3 Index

研究概览

简要总结

Determine whether personal optimization of the Omega-3 index improves cellular metabolism and quality of life (according to the SF-36 form).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant aged 19 or over
  • Available for the entire duration of the study and willing to participate on the basis of the information provided in the FIU duly read and signed.

排除标准

  • Allergy known to fish
  • Pregnant women who breast-feed or test positive for pregnancy

研究组 & 干预措施

MAG-EPA

Experimental

MAG-EPA softgel (500mg), daily dose between 1g and 3.5g

干预措施: MAG-EPA (Dietary Supplement)

结局指标

主要结局

Omega-3 Index

时间窗: 8 weeks

Achievement of an omega-3 index of 8.

次要结局

  • Heart rate(8 weeks)
  • Quality of life(8 weeks)
  • HDL-cholesterol(8 weeks)
  • Aspartate aminotransferase(8 weeks)
  • Bilirubin(8 weeks)
  • Albumin(8 weeks)
  • C-reactive protein(8 weeks)
  • Diastolic blood pressure(8 weeks)
  • Cellular metabolism(8 weeks)
  • Total Cholesterol(8 weeks)
  • Triglycerides(8 weeks)
  • Alanine aminotransferase(8 weeks)
  • LDL-cholesterol(8 weeks)
  • Apolipoprotein B(8 weeks)
  • Erythrocyte sedimentation rate(8 weeks)
  • Systolic blood pressure(8 weeks)

研究者

发起方
SCF Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验